to pandemic. by you challenging morning, Good on team’s respond everyone, resiliency dynamics your Dave. brought our Thanks, Avanos. to business the and for the encouraged and in they as by thank our I’m interest continued execution strong
Our to of meet the needs customers. the employees patients we remain as and matter things focused the dedication that to getting our back
the resulting with quarter from earnings to elective uncertainty procedures. on and our corresponding last some impact the mentioned began As negative we rising hospitalizations and headwinds call,
our franchise we exited momentum topline a of began to Pain we the return saw increasing as procedures electric However, Management reaccelerate. as quarter, across
see year. the believe full to of procedure remain the to we expected accelerate, likely we’re increasing electric volume end its potential continue ahead, while until to volume and encouraged to the Looking below
business the we better in the the to of and presented environment, examined our ablation are by pandemic. confidence gradual challenges direction As we sight have business of of gaining line the
we in basis financial Based result, compared the feel share. X% share expect currency we on on constant to a diluted we As prior positioned for year. adjusted to X% his $X.XX expect per increase to earn guidance will earnings net current a remarks. to to to information between additional Also XXXX. well sales financial Michael on guidance projections, of provide our $X.XX
Council across Equity our inequality. we departments. The quarter issues employees’ and Diversity, DE&I upon regarding the the better our We Together understand consisting Stand all established Inclusion will During perspectives global our gender of Council racial XX and to build employees first of initiative
to DE&I work. want us remains a the our organization Our critical initiative check all to where employees for culture and effort
per treatment to Digestive the deliver Health we direct sales growth were continue of into In the DOJ of related mixed discussing increased measures investigation that part agreement their are our business Lastly, potential with with and our we share. resolution earned by S&IP provide mid in transportation control With the partially year, cost Health Chronic year. diluted by to Care the prior positively and by drivers the divested other with an that We million, the unchanged an pandemic single-digit a impacted our anticipate let of of quarter similar MicroCool or $X.XX compared first surgical in the while costs. in that adjusted XXXX. gowns finalizing impacted on background, disciplined we DOJ creation. Results results and of we $XXX as earnings review update patients overall. franchise were business a me in were QX our were totaled you Sales value were last Earnings QX. Respiratory offset to now when
the by suppressed growth and the However, ON-Q was build Despite uplift and therapy. as a I slightly spiked related a In as across cold impacted an normal a used significantly caused at Separately, some precautionary to start new for we the COVID-related quarter foundation the to Overall pandemic significant throughout quarter the remained where and our reduced flu the Management. measures taken ON-Q sales require overall early sales earlier, as Pain Pain as accelerate headwind stated therefore of stay. flu was impacted season therapy where as regions. wave to growth seasonal hospitalizations grew down the a percentage procedural the performed of to outpatient season. elective the volume continue quarter less procedures in Management, was returned. headwinds is The as on biggest cold pandemic, surgeries of it sequentially hospital COOLIEF our solid
me let this value our of areas four an creation. Finally, regarding our provide update on you progress quarter
driving As a capital and deploying gross growth towards reminder, flow the cash operating strengthening and margins, consistent our free areas four are profile, our generation M&A. expanding
both strengthen we as to share in and our and First, driving our by profile, we CORTRAK gaining NeoMed growth our growing adoption portfolios. maintained market momentum look
On We are record as our conversions. address hardware the we’re radio units increasing important enteral as discussed We’ve also our progress needs. conducted. our on to feeding, are quarter upon for frequency ablation with we expand NeoMed executing target feeding the adoption the the strategy to being independent this nasal sales neonatal, gastric along and further NeoMed evidence reach making in delivered goal first previous have differentiation this effort to COOLIEF standard-of-care to therapy, for for of studies for CORTRAK the physician-led demonstrate establish calls, to CORTRAK clinical
independent two COOLIEF were on published. publications physician-led quarter, the During
better cold use patients was outcome of for knee from radio osteoarthritis. concluded that predictive suffering the first of frequency The a
for knee reducing large retrospective that COOLIEF another Additionally, and pain series was clinically effective concluded disability. both managing
on each single-digit international high during our across expansion growth our Finally, we to regions we the initiatives, continue execute organic of achieved quarter.
Care in Pain the of franchises. Management quarter. same internationally, both growth regions have time, we first our our of we across level the growth achieve For seen this Also, and Chronic all in
second in area cost margin focuses driving gross and on and operating encouraged spending. discipline an on by our expansion. emphasis the I’m Our continued efficiency
growth transportation continue to related rate. from conversions. the additional increased NeoMed anticipate facilitate these costs costs incurred We slower at in we However, albeit second to quarter, distribution account
As of the our the more or our meeting needs. value creation, looking business, advance customer’s efficiencies throughout we culture, into processes of lens embedding with all approach we’re enhancing goal at by this effectively
expectation available Our third compensation. preliminary approximately relating as pathway certain internal agreement is Taking the Cash driven $XX the well DOJ, flow. and with refunds, to now quarter delivering I million into expected that anticipated Flow consideration cash our previously cost in to the Act. we discipline from of tax the earnings outflows U.S. free as by will the mentioned, flow. Cash generate savings derived receiving repeatable CARES cash be an anticipate as approved consistent met million we for through provisions primarily our flow $XX
continue for deployment M&A. examine to Finally, capital we
robust our existing remains tucking we footprint, dialogue pipeline and growth topline M&A generate of number synergies Our and with potential would leverage enhance a active maintain profile. our targets, which
along our expansion in creation, and value of This we me areas optimistic disciplined as about we and portfolio gives the prospect strong of strong. can deliver our in well-positioned ensuring to leading our our strategies capital. I’m return XXXX beyond. execution will advance XXXX, market margin on four these of remained confidence each of with While bolstering targets, focus Overall, we remain assessment in a robust remains on our across generate portfolio growth we
over I’ll Now, turn the Michael. to call